Treatment With Intravenous Immunoglobulin and Steroids May Correct Severe Anemia in Hyperhemolytic Transfusion Reactions: Case Report and Literature Review

References 

1. Petz LD, Calhoun L, Shulman I, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:382–392
2. King KE, Shirey RS, Lankjewicz MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients’ red cells. Transfusion. 1997;37:376–381
3. Win N, New H, Lee E, et al. Hyperhemolysis syndrome in sickle cell disease: Case report (recurrent episode) and literature review. Transfusion. 2008;48:1231–1238
4. Treleaven JG, Win N. Hyperhemolysis syndrome in a patient with myelofibrosis. Hematology. 2004;9:147–149
   • MEDLINE
   • CrossRef
5. Darabi K, Dzik S. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion. 2005;45:1930–1933
6. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41:323–328
7. Win N, Tullie Y, Needs M, et al. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhemolysis syndrome in sickle cell disease. Hematology. 2004;9:433–436
   • MEDLINE
   • CrossRef
8. Mota MA, Sakashita AM, Hamerschlak N, et al. Post-transfusion hyperhemolysis after hemolytic transfusion reaction in a patient with severe anemia: Case report. Vox Sang. 2006;91(Suppl 3):233;Abstract
9. Muro M, Palacios S, Moya-Quiles R, et al. Acute hemolytic transfusion reactions secondary to human leukocyte antigen alloimmunization. In: International Journal of Laboratory Hematology. Blackwell Publishing Ltd.; 2007;p. 1–3[Letter to the Editor]
10. Anderson D, Ali K, Blanchette V, et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfusion Med. Rev. 2007;21:S9–S56